You searched for "lesion"
HS-UK to be authorised distributor for the Vision Engineering 3D Deep Reality Viewer
HS-UK is delighted to announce that it is now the authorised distributor for the Deep Reality Viewer (DRV) in the UK.Building leaders for eye care in Africa: the COECSA-RCOphth VISION 2020 LINK
The VISION 2020 LINK [1] between the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) and the Royal College of Ophthalmologists (RCOphth) has been building leaders of eye care in Africa since 2008, when a Memorandum of Understanding...RNIB launches new campaign to dispel myths and encourage people to ‘See the person, not the sight loss’
Leading sight loss charity RNIB (Royal National Institute of Blind People) and The&Partnership has today (3 October 2022) launched a new campaign ‘See the person, not the sight loss’, challenging outdated public attitudes and misperceptions of sight loss.Birdshot retinochoroiditis
Birdshot retinochoroiditis (BRC) is a chronic, sight-threatening uveitis, most commonly affecting caucasian individuals in their fourth to sixth decades [1]. The disease is associated with HLA-29 and is characterised by progressive inflammation at the level of retina and choroid, with...Typical or surprisingly uncharacteristic presentations of neuro-ophthalmic emergencies
Irrespective of geographical location or patient cohort, emergency departments are high risk locations capable of inspiring extreme anxiety and dread in patients and doctors alike. The stress multiplies when a walk-in or referred case is suspected of underlying neurological pathology....
Cataract surgery in patients with retinitis pigmentosa
Retinitis pigmentosa (RP) is the commonest inherited cause of retinal degeneration. Posterior subcapsular cataract (PSC) develops in 41% to 90% of these patients by age 40 years. In this retrospective study, the authors have evaluated surgical outcomes in patients with...
Visual outcomes and predictors in optic pathway glioma
This is a retrospective study of 60 paediatric optic pathway glioma (OPG) patients (NF1 or sporadic) presenting to Great Ormond Street between 2003-2017. Median follow-up was 82 months. Analysis was divided into best and worst eye vision representing level quality...
